Trading / Browse Companies / Apnimed Stock

Apnimed Stock

apnimed.comHealthcareFounded: 2017Funding to Date: $128.27MM

Apnimed is a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders.

Buy or sell Apnimed stockLearn more about a potential Apnimed IPO
Register for Details

For more details on financing and valuation for Apnimed, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Apnimed.

Register Today

Other companies like Apnimed in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM

Trending Companies

Frequently Asked Questions